Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Trends Endocrinol Metab. 2019 Aug 6;30(10):724–734. doi: 10.1016/j.tem.2019.07.016

Figure 2. Obesity phenotypes useful to personalize therapy and related treatments.

Figure 2.

(adapted from ref. 35, Camilleri, M. et al. (2016) Gastrointestinal traits: individualizing therapy for obesity with drugs and devices. Gastrointest. Endosc. 83, 48–56). GLP-1=glucagon-like peptide-1; RYGB=Roux-en-Y gastric bypass; LSG=laparoscopic sleeve gastrectomy